Evidence map›Paper›PMID 42532628›Full record

ArticleBMJ open respiratory research2026

Telomere dysfunction and mucociliary impairment drive idiopathic pulmonary fibrosis susceptibility: insights from a Sardinian whole-exome study.

Stefano Mocci, Roberto Littera, Silvia Deidda, Federica Cannas, Chiara Cocco, Michela Lorrai, Caterina Mereu, Michela Murgia, Giulia Nutile, Francesco Lai and 9 more

Abstract read
In one paragraph

Article in BMJ open respiratory research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Stefano Mocci *Medical Genetics, Department of Medical Sciences and Public Health, University of Cagliari, Cagliari, Italy.
Roberto Littera *Medical Genetics, R. Binaghi Hospital, Cagliari, Italy.
Silvia DeiddaPneumology Unit, R. Binaghi Hospital, Cagliari, Italy.
Federica CannasMedical Genetics, Department of Medical Sciences and Public Health, University of Cagliari, Cagliari, Italy.
Chiara CoccoMedical Genetics, Department of Medical Sciences and Public Health, University of Cagliari, Cagliari, Italy.
Michela LorraiMedical Genetics, Department of Medical Sciences and Public Health, University of Cagliari, Cagliari, Italy.
Caterina MereuMedical Genetics, Department of Medical Sciences and Public Health, University of Cagliari, Cagliari, Italy.
Michela MurgiaMedical Genetics, Department of Medical Sciences and Public Health, University of Cagliari, Cagliari, Italy.
Giulia NutileMedical Genetics, Department of Medical Sciences and Public Health, University of Cagliari, Cagliari, Italy.
Francesco LaiPediatric Clinic and Rare Diseases, Microcitemico Hospital "A.Cao", Department of Medical Sciences and Public Health, University of Cagliari, Cagliari, Italy.
Celeste SannaMedical Genetics, Department of Medical Sciences and Public Health, University of Cagliari, Cagliari, Italy.
Laura ServentiMedical Genetics, Department of Medical Sciences and Public Health, University of Cagliari, Cagliari, Italy.
Gaia TosoneMedical Genetics, Department of Medical Sciences and Public Health, University of Cagliari, Cagliari, Italy.
Elena ZeddaMedical Genetics, Department of Medical Sciences and Public Health, University of Cagliari, Cagliari, Italy.
Erika GiuressiMedical Genetics, R. Binaghi Hospital, Cagliari, Italy.
Sara LaiMedical Genetics, R. Binaghi Hospital, Cagliari, Italy.
Andrea PerraOncology and Molecular Pathology Unit, Department of Biomedical Sciences, University of Cagliari, Cagliari, Italy.
Matteo FlorisMedical Genetics, Department of Medical Sciences and Public Health, University of Cagliari, Cagliari, Italy matteo.floris@gmail.com.ORCID http://orcid.org/0000-0003-4385-9336
Sabrina GiglioCentre for Research University Services (CeSAR, Centro Servizi di Ateneo per la Ricerca), University of Cagliari, Cagliari, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIdiopathic pulmonary fibrosis (IPF) is a progressive interstitial lung disease in which both environmental exposures and genetic predisposition contribute to disease susceptibility. Studying the burden of rare variants in a genetically homogeneous founder population may help identify disease-associated alleles that are difficult to detect in more heterogeneous populations.

methodsWhole exome sequencing was performed on 123 patients with IPF and 1110 unrelated controls from Sardinia (Italy). Variant prioritisations were conducted according to the American College of Medical Genetics (ACMG) guidelines. In parallel, gene burden of rare predicted loss-of-function variants was assessed using the Cohort Allelic Sums Test (CAST) algorithm to identify genes significantly enriched in IPF cases compared with controls.

resultsPathogenic or likely pathogenic variants in known telomere-related genes were identified in 11.4% of patients. These variants were associated with younger age at diagnosis and a higher prevalence among never-smokers. CAST analysis identified a significant enrichment of loss-of-function variants in 82 genes, including

conclusionsThis study supports the contribution of telomere-related variants to IPF susceptibility and suggests a possible role for rare variants affecting mucociliary pathways. Together, these findings broaden the current understanding of IPF biology in this cohort. The distinctive genetic background of the Sardinian population may have facilitated the identification of rare or population-specific variants, underscoring the potential value of founder populations in complex disease genetics.

Indexed as

Genetic Predisposition to DiseaseIdiopathic Pulmonary FibrosisTelomereAgedCase-Control StudiesExome SequencingFemaleHumansItalyMaleMiddle AgedMucin-5BMUC5B protein, humanMucin-5BIdiopathic Pulmonary Fibrosis

Identifiers

PMID42532628
PMCPMC13423060

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.